KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that five abstracts, including one late-breaking submission, have been accepted for presentation at the 2026 Global Angioedema Leadership ...

Features now not included in Java releases will be added, while Java theme ambitions plan for easier use for immutable data ...

Seattle-based Sabey Corp. plans to build the facility on 130 acres near the northeast corner of Kentucky Avenue and Camby ...

Alessa Therapeutics (“Alessa”), a clinical-stage biopharmaceutical company advancing novel localized drug delivery technology ...